Company Overview
Snapshot
Founded in December 2016 by Uri Arnin and Yizhar Floman, ZygoFix operates with 1–10 employees. The company has secured $8.96 million across 4 funding rounds from 6 investors. In June 2021, ZygoFix received CE Clearance for its zLOCK Spinal Fusion System.
Business overview
ZygoFix is a Health Tech & Life Sciences company focused on developing medical devices for spinal fusion procedures. The company's core product is the zLOCK miniature 3D printed implant, designed as a screwless solution for spinal stability. This minimally invasive technology aims to eliminate risks associated with traditional screw-based methods and can be performed in an outpatient setting. ZygoFix serves the healthcare industry, specifically targeting clinics, hospitals, and orthopedic surgeons with its innovative spinal fusion system.
Strategic signal
In June 2021, ZygoFix received CE Clearance for its zLOCK Spinal Fusion System, marking a significant regulatory milestone. This clearance allows the company to market its device within the European Economic Area, validating its technology and opening up a major market for commercialization. For investors, this signals a critical step towards broader adoption and revenue generation, positioning ZygoFix for potential growth in the competitive spinal implant market.
Log in to access full profile ›Company Intelligence Q&A
- What is ZygoFix's primary product?
- ZygoFix's primary product is the zLOCK miniature 3D printed implant, a screwless spinal fusion system designed to utilize the spine's own anatomy for stability.
- When did ZygoFix receive CE Clearance for its zLOCK system?
- ZygoFix received CE Clearance for its zLOCK Spinal Fusion System in June 2021.
- Which investors participated in ZygoFix's March 2021 funding round?
- In March 2021, ZygoFix completed a funding round with participation from Agriline and ExitValley.
- When was ZygoFix founded and by whom?
- ZygoFix was founded in December 2016 by Uri Arnin and Yizhar Floman.
- Has ZygoFix conducted any 'first-in-human' trials?
- Yes, ZygoFix announced successful 'first-in-human' trials for its spinal facet joint fixation system in December 2018.